Expansion Therapeutics Raises $80 Million Series B Financing To Treat Neurodegenerative Diseases
Amount Raised
$80 Million
Round Type
Series B
Del MarBiotechnologyHealthcareScience And EngineeringDescription
Expansion Therapeutics, Inc., a biotechnology company focused on developing transformative oral medicines for severe RNA-mediated diseases, today announced the close of an $80 million Series B financing. Cormorant Asset Management led the financing with participation from new investors Westlake Village BioPartners, Surveyor Capital (a Citadel company) and Logos Capital as well as Series A investors RA Capital Management, 5AM Ventures, Kleiner Perkins, Sanofi Ventures and Novartis Venture Fund. Proceeds from the financing will be used to advance the company’s small molecule RNA platform (SMiRNATM) to identify clinical candidates in myotonic dystrophy type 1 (DM1), amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD) and various tauopathies.
Quick answer
Expansion Therapeutics raised $80 Million in a Series B round, dated September 29, 2021. Expansion Therapeutics is based in Del Mar, California, United States.
- How much did Expansion Therapeutics raise?
- Expansion Therapeutics raised $80 Million in a Series B round on September 29, 2021.
- What does Expansion Therapeutics do?
- Expansion Therapeutics is a biotechnology company focused on developing transformative oral medicines for severe RNA-mediated diseases including neurodegenerative disorders.
- Where is Expansion Therapeutics based and how big is it?
- Expansion Therapeutics is based in Del Mar, California, United States.
Source: Fundz verified event record.
Who else raised in Healthcare and Science And Engineering around the same time
Companies in the same sectors as Expansion Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- RedHill Biopharma Ltd raised an undisclosed amount (Corporate Round) on November 8, 2021.
- Athos Therapeutics, Inc. raised $13M on September 28, 2021.
- Sydnexis raised $46M on August 18, 2021.
- Clade Therapeutics raised $46M on November 12, 2021.
- Ankyra Therapeutics raised $45M (Series B) on November 12, 2021.
- HealthSnap raised $5M on November 10, 2021.
Who to call at Expansion Therapeutics, and when
A new round usually means Expansion Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Expansion Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Expansion Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Expansion Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Expansion Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansExpansion Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.